A Study to Evaluate the Pharmacokinetics of HSK16149 in Subjects With Renal Impairment
Clinical trial NCT05916573 · COMPLETED
Trial details
- NCT number
- NCT05916573
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-12
- Primary completion
- 2023-02-27
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.